Cargando…
Probing Gut Participation in Parkinson’s Disease Pathology and Treatment via Stem Cell Therapy
Accumulating evidence suggests the critical role of the gut–brain axis (GBA) in Parkinson’s disease (PD) pathology and treatment. Recently, stem cell transplantation in transgenic PD mice further implicated the GBA’s contribution to the therapeutic effects of transplanted stem cells. In particular,...
Autores principales: | Lee, Jea-Young, Castelli, Vanessa, Sanberg, Paul R., Borlongan, Cesar V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342034/ https://www.ncbi.nlm.nih.gov/pubmed/37445778 http://dx.doi.org/10.3390/ijms241310600 |
Ejemplares similares
-
Gutting the brain of inflammation: A key role of gut microbiome in human umbilical cord blood plasma therapy in Parkinson's disease model
por: Lee, Jea‐Young, et al.
Publicado: (2019) -
Inflammatory gut as a pathologic and therapeutic target in Parkinson’s disease
por: Lee, Jea-Young, et al.
Publicado: (2022) -
Eye Opener in Stroke: Mitochondrial Dysfunction and Stem Cell Repair in Retinal Ischemia
por: Nguyen, Hung, et al.
Publicado: (2019) -
A Gutsy Move for Cell-Based Regenerative Medicine in Parkinson’s Disease: Targeting the Gut Microbiome to Sequester Inflammation and Neurotoxicity
por: Lee, Jea-Young, et al.
Publicado: (2019) -
Correction to: A Gutsy Move for Cell-Based Regenerative Medicine in Parkinson’s Disease: Targeting the Gut Microbiome to Sequester Inflammation and Neurotoxicity
por: Lee, Jea-Young, et al.
Publicado: (2022)